En Es
Categories

Industry News

Top Trends Impacting Global Wearable Devices Market

By HospiMedica International staff writers
08 Sep 2017

Image: The global market for wearable medical devices is projected to grow at a CAGR of more than 9% by 2021 (Photo courtesy of iStock).The global market for wearable medical devices is projected to grow at a CAGR of more than 9% from 2017-2021, driven mainly by the increasing prevalence of chronic diseases, growing need for cost-effective diagnosis and treatment, and increasing number of compatible smartphone applications. These are the latest findings of Technavio Research, (London, UK), a global technology research and advisory company.

Increasing prevalence of chronic diseases: People suffering from chronic diseases such as diabetes and asthma require constant monitoring and are therefore, adopting wearable medical devices, which help to reduce costs and the burden of hospital visits. CVDs are estimated to cause approximately 19 million deaths by 2020, while asthma accounts for six to seven in every 1,000 deaths annually. The number of people aged 65 years and above is expected to rise to about 1.6 billion by 2050. The rising prevalence of CVDs such as stroke and chronic respiratory diseases like asthma, coupled with the increase in aging population is expected to lead to higher demand for wearable medical devices.

Growing need for cost-effective diagnosis and treatment: The treatment of chronic diseases such as diabetes, asthma, and cancer is significantly less expensive and easier to manage when detected at an early stage. Smart wearables allow early detection of such diseases, thereby helping in their effective management. Self-monitoring of medical conditions using connected wearable medical devices helps reduce costs and promote healthier lifestyles. For instance, wearable ECG portable machines are more cost effective for people in need of regular ECG monitoring. Similarly, people suffering from CVDs can use wearable medical devices to detect AF instead of undergoing multiple ECG tests at hospitals.

Increasing number of compatible smartphone applications: The increasing adoption of smartphones is also driving the growth of the global wearable medical devices market. With the advent of smart wearables, there has been a significant increase in the scope for remote monitoring. Wearable patient monitoring devices record various vital signs such as heart rate, respiratory rate, skin temperature, and glucose levels, thus generating significant volume of data in the process that can be analyzed using smartphones. For instance, companies such as Fitbit and Garmin have launched wearable medical devices which are compatible with smartphones for monitoring heart rhythms, sleep, and calories.

“Wearable devices that are connected with cloud-based monitoring technologies enable digital remote monitoring and reduce hospital expenditure and costs. These products are gaining popularity among consumers and are expected to witness increased adoption due to reducing prices,” said Ramakrishna Edupulapati, a lead analyst at Technavio for orthopedics and medical devices research. “The global smart devices market is growing rapidly, as vendors are making significant investments in R&D to develop new products. With innovative technologies, cloud computing, and machine learning, the use of smartphones with specific applications will drive the demand for wearable medical devices.”

Related Links:
Technavio Research



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

23 Feb 2018
AI Applications Predict Part Failures in Imaging Modalities
Machine data analytics company, Glassbeam, Inc. has built Artificial Intelligence (AI) applications powered by Machine Learning (ML) models for predicting part failures in expensive imaging modalities. The new applications delivered in real time through cloud-based dashboards and rules-based alerts are expected to change the way equipment maintenance is currently performed by in-house support staff at healthcare providers, independent service organizations (ISOs), and OEMs.
Read More
23 Feb 2018
Top Factors Driving Global POC Glucose Monitoring Devices Market
The global market for POC blood glucose monitoring devices is expected to grow at a CAGR of over 8% during the period 2018-2022, driven mainly by public and private initiatives to reduce diabetic cases. These are the latest findings of Technavio Research, a global technology research and advisory company.
Read More
21 Feb 2018
Stroke Detection Software Receives FDA Clearance
The US FDA has approved a new clinical decision support software that notifies neurologists about a potential stroke in their patients by analyzing computed tomography (CT) results. The tool named Contact has been developed by Viz.ai, a direct-to-intervention healthcare company that uses artificial intelligence (AI) and deep learning algorithms to analyze medical data and improve medical workflow.
Read More
21 Feb 2018
AI in Medical Imaging to Surge in Coming Years
The use of machine learning or artificial intelligence (AI) technology by hospitals and imaging centers is expected to surge by 2020, with its highest application to be in the area of breast imaging.
Read More
21 Feb 2018
New Deep Learning-Based Algorithm Can Assess Breast Density
Researchers from the University of Pittsburgh Medical Center have developed a new deep learning-based algorithm for breast density segmentation and estimation that correlated well with BI-RADS density assessments by radiologists and also outperformed an existing state-of-the-art algorithm.
Read More
13 Feb 2018
QIAGEN Enters into Agreement to Acquire STAT-Dx
QIAGEN N.V. has entered into an agreement to acquire STAT-Dx, a privately-held company which develops next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes using a novel system based on real-time PCR technology and proven QIAGEN chemistries.
Read More
08 Feb 2018
AI Could Learn How to Understand Radiologist Reports
Researchers at the Icahn School of Medicine at Mount Sinai have used machine learning techniques, including natural language processing algorithms, to identify clinical concepts in radiologist reports for computed tomography (CT) scans. The technology marks an important first step in the development of artificial intelligence (AI) that could interpret scans and diagnose conditions.
Read More
08 Feb 2018
AR and VR in Healthcare Market to Reach USD 4.9 Million by 2023
The augmented reality (AR) and virtual reality (VR) in the healthcare market was valued at USD 769.2 million in 2017 and is expected to grow at a CAGR of 36.6% during the forecast period to reach USD 4,997.9 million by 2023. The market growth will be driven by increasing penetration of connected devices in the healthcare sector, rising investment in healthcare AR and VR, and growing need to reduce healthcare costs. However, the lack of competence in the deployment of AR and VR solutions, and lack of expertise among medical practitioners to adopt new technologies are the major restraints for market growth.
Read More
08 Feb 2018
Elekta Collaborates with IBM Watson Health to Bring AI to Oncology
Elekta is collaborating with IBM Watson Health to offer Watson for Oncology with its cancer care solutions. Beginning in early 2018, Elekta will sell Watson for Oncology as a clinical decision support solution, paired within its digital cancer care solutions, including the MOSAIQ Oncology Information System.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions